Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals, or no treatment: a retrospective cohort study (BMC Infectious Diseases, 2024)

(untitled) - Drysdale, M; Tibble, H; Patel, V; Gibbons, DC; Lloyd, EJ; Kerr, W; Macdonald, C; Birch, HJ; Sheikh, A